Here, we have determined MVD using a pan-endothelial marker and CD105 in colorectal cancers and have quantified plasma levels of TGFβs (viz., 1 and 3) and their receptor, CD105 and receptor–ligand complexes. The gene discussed is ENG; the disease is colorectal cancer.